- SCPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
scPharmaceuticals (SCPH) 8-K13 Mar 24Generated full-year net FUROSCIX® revenue of $13.6 million, at the upper end of the range provided in JanuaryFinancial data
Company Profile